Sangamo Therapeutics (SGMOQ) Gains from Investment Securities (2014 - 2015)
Sangamo Therapeutics (SGMOQ) posted quarterly Gains from Investment Securities of -$1.8 million for Q1 2015, down 3700.0% year-over-year from $50000.0 in Q1 2014, and down 1900.0% quarter-over-quarter from $100000.0 in Q4 2014.
Sangamo Therapeutics (SGMOQ) Gains from Investment Securities (2014 - 2015) Analysis & Trends
Sangamo Therapeutics' Gains from Investment Securities history runs 2 years deep, the most recent figure standing at -$1.8 million for Q1 2015.
- In Q1 2015, Gains from Investment Securities fell 3700.0% year-over-year to -$1.8 million; the TTM figure through Dec 2015 stood at -$1.8 million (down 882.61% YoY), while the FY2015 annual figure was -$1.8 million, down 882.61% from the prior year.
- Gains from Investment Securities for Q1 2015 stood at -$1.8 million, down from $100000.0 in the prior quarter.
- The five-year high for Gains from Investment Securities was $100000.0 in Q4 2014, with the low at -$1.8 million in Q1 2015.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2015 | -1.80 Mn |
| Mar 31, 2015 | -1.80 Mn |
| Dec 31, 2014 | 100,000.00 |
| Dec 31, 2014 | 100,000.00 |
| Sep 30, 2014 | 50,000.00 |
| Sep 30, 2014 | 50,000.00 |
| Jun 30, 2014 | 30,000.00 |
| Jun 30, 2014 | 30,000.00 |
| Mar 31, 2014 | 50,000.00 |
| Mar 31, 2014 | 50,000.00 |